Reviva Pharmaceuticals Holdings, Inc.
RVPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13 | $23 | $19 | $30 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $0 | $2 |
| Total Curr. Assets | $15 | $24 | $19 | $31 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $404 | $2 |
| Total NC Assets | $1 | $0 | $404 | $2 |
| Other Assets | $0 | $0 | -$404 | -$2 |
| Total Assets | $16 | $24 | $19 | $31 |
| Liabilities | – | – | – | – |
| Payables | $6 | $4 | $4 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $13 | $6 | $2 |
| Total Curr. Liab. | $15 | $17 | $10 | $2 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $1 | $0 |
| Total NC Liab. | $0 | $1 | $1 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15 | $18 | $11 | $3 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$164 | -$134 | -$95 | -$67 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $165 | $140 | $103 | $96 |
| Total Equity | $1 | $6 | $8 | $29 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $16 | $24 | $19 | $31 |
| Net Debt | -$13 | -$23 | -$19 | -$30 |